Colony Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-7,299
Closed -$725K 776
2019
Q3
$725K Buy
7,299
+179
+3% +$17K 0.02% 420
2019
Q2
$658K Buy
7,120
+122
+2% +$11.6K 0.02% 454
2019
Q1
$660K Buy
+6,998
New +$612K 0.03% 344
2018
Q4
Sell
-3,220
Closed -$288K 561
2018
Q3
$288K Sell
3,220
-77
-2% -$6.8K 0.01% 420
2018
Q2
$262K Sell
3,297
-411
-11% -$34.1K 0.01% 432
2018
Q1
$331K Sell
3,708
-153
-4% -$14.7K 0.02% 381
2017
Q4
$403K Buy
3,861
+94
+2% +$10.6K 0.03% 349
2017
Q3
$549K Sell
3,767
-69
-2% -$9.4K 0.04% 279
2017
Q2
$498K Buy
3,836
+1,173
+44% +$144K 0.04% 288
2017
Q1
$331K Sell
2,663
-503
-16% -$60.2K 0.03% 225
2016
Q4
$366K Buy
3,166
+98
+3% +$10.9K 0.04% 218
2016
Q3
$321K Sell
3,068
-16,015
-84% -$1.73M 0.04% 212
2016
Q2
$1.88M Sell
19,083
-97,236
-84% -$10.1M 0.21% 106
2016
Q1
$11.6M Sell
116,319
-1,917
-2% -$197K 1.35% 25
2015
Q4
$14.2M Buy
118,236
+1,241
+1% +$144K 1.29% 20
2015
Q3
$12.7M Buy
116,995
+1,396
+1% +$173K 1.47% 15
2015
Q2
$13.4M Buy
115,599
+2,005
+2% +$229K 1.41% 18
2015
Q1
$13.1M Sell
113,594
-16,550
-13% -$1.98M 1.45% 15
2014
Q4
$14.6M Buy
130,144
+15,031
+13% +$1.59M 1.52% 12
2014
Q3
$10.9M Sell
115,113
-415
-0.4% -$37.5K 1.22% 23
2014
Q2
$9.92M Sell
115,528
-16,090
-12% -$1.22M 1.32% 31
2014
Q1
$9.19M Sell
131,618
-2,090
-2% -$166K 1.24% 33
2013
Q4
$11.3M Buy
+133,708
New +$10.6M 1.57% 19

Other funds holding CELG

Colony Group's CELG Position: Q4 2019 in Review

Colony Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,299 shares — an estimated $725K sold.

Colony Group first reported a position in CELG in Q4 2013 and held it in 23 quarters. The position peaked at $14.6M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Colony Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Colony Group sold 7,299 Celgene Corp shares in Q4 2019, an estimated $725K.
  • Colony Group first reported a position in Celgene Corp in Q4 2013 and held it in 23 quarters.
  • Colony Group's Celgene Corp position peaked at $14.6M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Colony Group's 13F filing for Q4 2019, filed 18 Feb 2020.